Pemphigus Vulgaris: Blisters, Diagnosis, and Treatment

Pemphigus vulgaris (PV) is a rare autoimmune blistering condition that can affect the skin and the moist lining of the mouth and other areas. Fragile blisters often break into painful sores. Early specialist assessment matters because extensive disease can affect eating, hydration, and skin protection.

Medical information: This educational guide cannot diagnose PV or replace medical care. New, unexplained blisters or persistent painful mouth sores should be assessed by a clinician; treatment needs specialist supervision.

What pemphigus vulgaris is

Pemphigus vulgaris (PV) is a rare autoimmune blistering disease that affects skin and moist linings called mucous membranes. It often begins with painful erosions inside the mouth; fragile blisters on the skin may appear later. Because the blisters break easily, a person may mainly notice raw, sore areas rather than intact blisters. PV can also affect the nose, throat, eyes, genitals, or other mucosal surfaces.

In healthy skin, proteins help hold neighboring skin cells together. In PV, the immune system makes antibodies against some of these proteins, especially desmogleins. The cells lose their connections, fluid collects between them, and a fragile blister forms. The precise reason the immune system starts doing this is not fully understood. PV is not caused by poor hygiene, an infection, or contact with another person.

PV needs timely medical assessment because extensive skin or mouth erosions can cause pain, infection, loss of fluid, dehydration, and difficulty eating. Treatment can control disease, but the medicines themselves can have important risks and require specialist supervision. This guide explains common features and the usual diagnostic and treatment approach; it cannot diagnose an individual.

Early symptoms often involve the mouth

Many people first notice painful areas inside the mouth. A blister may appear briefly and then rupture, leaving a shallow red or raw erosion. Common sites include the inner cheeks, gums, tongue, palate, and throat. Eating acidic, spicy, crunchy, or hot foods may hurt. Brushing teeth, drinking, or speaking can also become uncomfortable.

Oral sores may be mistaken for canker sores or irritation, especially before there are skin findings. A sore that repeatedly returns, spreads, heals slowly, or occurs alongside easy blistering of the skin needs evaluation. Mouth symptoms can precede skin lesions by weeks or months, and some people have mostly mucosal disease. The absence of a visible skin blister does not rule out PV.

If sores extend toward the throat or voice box, swallowing may hurt and the voice may become hoarse. Nasal involvement can cause crusts, congestion, or bleeding. Eye-surface involvement can cause redness, irritation, or light sensitivity. These symptoms have many possible explanations, but in a person with suspected PV they should be assessed promptly because mucosal surfaces can be delicate.

Skin blisters and erosions

On the skin, PV blisters are often soft and fragile rather than tense. They may contain clear fluid, arise on skin that looks normal or mildly inflamed, and break with minimal friction. After a blister opens, the exposed area may ooze, crust, or feel raw and painful. Lesions can appear on the scalp, face, upper trunk, back, or other sites and may heal slowly, sometimes leaving temporary color change.

On darker skin, inflammation may not appear bright red. A blister or erosion can look darker, purplish, or like a change in surface texture, and a crust may be more visible than redness. The range of skin tones matters in assessment. A clear description of symptoms and timing, together with a professional examination, is more useful than comparing a lesion with a photograph online.

PV lesions can be widespread or limited. The number and location of erosions, mouth involvement, pain, and effects on eating or hydration help the care team judge how active and severe the disease is. Do not rub the skin to see whether it peels, and do not deliberately break blisters. Fragile skin is easily injured, and a test that a clinician may perform during an examination is not safe or useful as a home check.

Other areas that may be affected

PV can involve mucosal surfaces beyond the mouth. The nose, throat, eyes, genitals, urinary opening, or anus may be affected. Symptoms depend on the site and can include crusting, pain, bleeding, difficulty swallowing, hoarseness, eye redness, genital soreness, or pain when urinating or passing stool. Not everyone develops these symptoms.

If the eyes are painful, red, light-sensitive, or vision changes occur, an eye specialist may need to assess the surface. If swallowing or voice changes suggest involvement of the throat or larynx, the treating team may seek input from an ear, nose, and throat specialist. These referrals are based on the individual symptoms rather than being necessary for every patient.

PV may also affect skin around the nails, causing tenderness or inflammation. Severe disease can influence sleep, activity, eating, work, and emotional well-being. The combination of pain, slow healing, and uncertainty about new blisters can be exhausting. Care should address symptom relief and daily function alongside the immune disease.

Why early recognition matters

Large areas of raw skin can become infected and allow the body to lose fluid and protein. Painful mouth erosions can make it difficult to drink or eat enough, leading to dehydration, weight loss, or nutritional problems. A person taking immune-suppressing medicine may also be more vulnerable to certain infections. These complications are part of why PV should be managed by clinicians familiar with autoimmune blistering disease.

PV is not the same as bullous pemphigoid, another autoimmune blistering disease. The blisters in PV tend to be more fragile and PV often affects the mouth; bullous pemphigoid more often causes firm, tense blisters and commonly affects older adults. These are general patterns, not a way to identify a condition at home. Biopsy and laboratory testing are often needed because several disorders can look similar.

Some medicines have been associated with drug-induced pemphigus in rare cases. Tell the clinician about every prescription medicine, supplement, and recent change, but do not stop a medicine on your own. The prescriber can review whether a drug might be relevant and how to change therapy safely if needed.

How pemphigus vulgaris is diagnosed

Diagnosis begins with a detailed history and examination. A dermatologist asks when the first sores appeared, how quickly they spread, whether there are mouth or eye symptoms, and whether eating, drinking, speaking, or urination has changed. The clinician checks the skin and mucosal surfaces that can be examined safely. A dentist, oral medicine clinician, or eye specialist may contribute when those areas are affected.

A biopsy is usually needed to confirm suspected PV. One small sample is taken from an active blister or erosion for routine microscopic examination. A separate sample of nearby skin that looks less damaged may be taken for direct immunofluorescence, a laboratory method that can show the characteristic immune deposits. The location and handling of each sample matter, so it is best done by a clinician familiar with blistering disorders.

Blood tests can detect circulating antibodies against desmoglein proteins and may support diagnosis. Antibody levels can also help the specialist follow disease activity over time, although results are interpreted with symptoms and examination. A blood test alone does not replace biopsy or establish how severe the condition is.

The care team may also check for infection, dehydration, nutrition problems, or complications of medicines. Depending on the symptoms, this may include blood counts, chemistry tests, infection testing, or a careful review of oral intake. These tests guide safe treatment; they are not all required for every person.

Treatment is specialist-led

Treatment aims to stop new blisters from forming, heal existing erosions, reduce pain, and prevent infection and fluid loss. The choice depends on how extensive the disease is, whether mucous membranes are affected, the person's other health conditions, and the risks of each medicine. Most people need treatment that works throughout the body because PV is an immune-driven disease affecting more than one patch of skin.

Rituximab is a targeted biologic medicine used for moderate to severe pemphigus vulgaris in adults in the United States and is included as an important treatment option in specialist recommendations. It acts on B cells involved in making disease-related antibodies. It is given under medical supervision, commonly with a corticosteroid plan or another tailored regimen. Availability, approval, and preferred treatment may differ by country and clinical circumstances.

Systemic corticosteroids can reduce inflammation and may be used as part of disease control. Other immune-modulating medicines, such as azathioprine or mycophenolate, may be considered to help control disease or reduce the need for prolonged steroid exposure. Some patients need additional therapies if disease remains active or returns. No one should start, stop, taper, or combine these medicines without the specialist's guidance; abrupt steroid withdrawal can be dangerous.

Because immune therapies can affect infection risk and other body systems, the team reviews past infections, other diagnoses, vaccinations, pregnancy plans where relevant, and current medicines. Some treatments require blood tests or screening before and during therapy. The prescriber explains expected benefit, possible side effects, monitoring, and what to do if fever or a new infection develops. A serious infusion reaction is possible with rituximab, so it is administered where medical support is available.

Severe disease may require hospitalization. Hospital care can provide wound support, pain relief, fluids, nutrition, and treatment of infection while specialists bring the immune disease under control. This does not mean that every person with PV needs admission; the decision depends on body surface involved, oral intake, infection, pain, and other clinical findings.

Wound care, oral comfort, and nutrition

Fragile skin benefits from gentle handling. The treating team may recommend a dressing or bland ointment for open erosions and can show how to protect the area without pulling at the skin. Avoid adhesive products or harsh cleansers unless the clinician says they are appropriate. Do not share prescription creams, use leftover antibiotics, or apply strong antiseptics to large areas without medical advice.

Painful mouth lesions may make eating difficult. Softer foods and cooler liquids may be easier to tolerate; avoid foods that sting or scrape the sores. A dentist or oral medicine professional can suggest ways to protect teeth and gums while brushing is painful. If drinking becomes difficult, urine output drops, dizziness develops, or weight falls, contact the treating team promptly because hydration and nutrition may need direct support.

Take care with any mouth rinse or numbing product: some can irritate the tissue or mask worsening symptoms. Ask a clinician or pharmacist which products are suitable and how often they can be used. If the throat or voice is affected, do not rely on home remedies; tell the dermatologist or specialist, especially if swallowing or breathing is becoming difficult.

Rest, practical help, and emotional support can be important during flares. The disease is not contagious, so ordinary household contact does not require separation. If wounds are open, follow the care team's hygiene advice to lower the risk of infection. Keep scheduled follow-up even when symptoms improve, because the team may adjust treatment gradually.

How doctors monitor the disease

At follow-up, the care team may record where blisters and erosions are appearing, whether new lesions continue, how quickly existing ones heal, and whether mouth, eye, or other mucosal symptoms have changed. Standardized severity scores can help dermatology teams compare disease activity over time. Photographs may be used with consent and stored securely as part of the medical record.

Antibody levels may be followed in some patients, but a laboratory result is only one part of the assessment. A person may feel better before all tests normalize, or a change in a test may not directly match symptoms. The clinician combines test results with examination and the overall pattern before changing treatment.

Monitoring also considers treatment effects. Blood counts, liver or kidney tests, infection screening, bone health measures, or other checks may be selected based on the medicine. Tell the care team about fever, new mouth sores, skin redness or pus, unusual bruising, or other new symptoms. Do not delay reporting a possible adverse effect because the disease itself is being treated.

When to seek urgent or emergency care

Seek urgent medical care if skin blisters or erosions are spreading quickly, large areas are raw, or pain is preventing normal activity. Fever, chills, worsening redness, pus, foul-smelling drainage, or feeling very unwell can indicate infection. People taking immune-suppressing medicines should report possible infection promptly, even if symptoms initially seem mild.

Get prompt help if mouth pain makes it hard to drink, urine becomes unusually dark or infrequent, dizziness or weakness develops, or there are signs of dehydration. Trouble swallowing saliva, breathing difficulty, sudden hoarseness with throat symptoms, severe eye pain, or a change in vision needs urgent assessment. Use local emergency services for severe breathing difficulty or other immediate emergencies.

If you already have a PV diagnosis, contact the treating team for new blisters or ulcers rather than waiting for the next routine appointment. Do not increase your medicine dose, restart an old prescription, or stop corticosteroids without advice. Early review can help manage a flare and reduce the risk of complications.

Course and outlook

PV often follows a chronic course with periods of greater activity and periods of improvement. With specialist treatment, many people achieve control of new blister formation and healing of erosions. Some require long-term monitoring or maintenance treatment; flares can recur. The course differs widely, and a single symptom or blood test cannot predict exactly when a flare will happen.

Treatment has greatly improved the outlook, but immune-suppressing medicines can have serious side effects. The care plan balances controlling PV against reducing the risks of infection, medication toxicity, and steroid-related complications. That balance is reviewed over time as the disease responds.

Support from a dermatologist, dentist, nurse, primary care clinician, and other specialists can make care more coordinated. Ask for one clear contact pathway for medication questions, worsening blisters, and urgent symptoms. Patient support organizations can also help people navigate the practical and emotional parts of a rare condition.

Questions to discuss with a dermatologist

Ask what findings support the diagnosis, which biopsy tests are planned, and whether blood antibody tests will help monitor your disease. Ask how the team will judge disease control, what symptoms should prompt an earlier call, and which medicines are being considered. It is useful to know how infection risk will be monitored and whether any vaccines or routine health checks should be planned before treatment.

If mouth sores are affecting eating, ask about pain control, oral care, hydration, and nutrition support. If the eyes, nose, throat, or genitals are involved, ask whether another specialist should examine those areas. Tell the care team about new medicines, planned surgery, pregnancy considerations, or prior infections, as these may affect the treatment plan.

Write down questions before appointments and bring a current medicine list. When instructions are complex, ask the clinician to explain the daily plan in writing, including what to do after a missed dose or if a new infection develops. Clear instructions help prevent accidental treatment changes.

Key takeaways

Pemphigus vulgaris is a rare autoimmune disease that causes fragile blisters and painful erosions, often beginning in the mouth. It is not contagious. Diagnosis usually combines examination, biopsy with specialized immunofluorescence, and sometimes blood antibody testing. Specialist treatment may include rituximab, corticosteroids, or other immune-modifying medicines, with wound and supportive care. Widespread sores, dehydration, infection, difficulty swallowing or breathing, and eye symptoms need prompt medical attention.

Frequently asked questions

Sources and further reading

These dermatology, patient, and public-health resources informed this overview. Medication choices and emergency advice should be confirmed with the treating medical team.

• DermNet: Pemphigus vulgaris
• MedlinePlus Medical Encyclopedia: Pemphigus vulgaris
• British Association of Dermatologists: Pemphigus vulgaris
• NIAMS: Pemphigus diagnosis, treatment, and steps to take
• DailyMed: Rituxan prescribing information
• International panel recommendations for pemphigus diagnosis and management

Editorial note: Rituximab is indicated for adults with moderate-to-severe PV in the United States; treatment options and regulatory status vary by location. Only a qualified specialist can recommend an individual regimen.